Related Experiment Video
Updated: Oct 21, 2026
Improved Rodent Model of Myocardial Ischemia and Reperfusion Injury
Published on: March 7, 2022
Delayed endothelial protective effects of monophosphoryl lipid A after myocardial ischemia and reperfusion in rats
V Richard1, E Danielou, N Kaeffer
1Department of Pharmacology (VACOMED, IFRMP 23), Rouen University Medical School and Rouen University Hospital, Rouen, France.
Abstract:
Monophosphoryl lipid A (MLA) induces delayed (24 h) myocardial protection in various animal models of ischemia/reperfusion injury, and thus mimics the second window of preconditioning against cardiac injury. However, the potential endothelial protective effects of this drug have not been evaluated. The present study was designed to assess whether MLA exerts delayed protective effects against reperfusion-induced coronary endothelial dysfunction in rats, as well as the protective role of iNOS in this protection. Wistar rats received a single i.v. injection of MLA (450 microg/kg) or solvent. Twenty-four hours later, they were anesthetized and subjected to 20 min ischemia with 60 min reperfusion, in the absence or the presence of the iNOS inhibitor aminoguanidine (300 mg/kg i.p.). At the end of reperfusion, 1.5-2 mm coronary segments (average diameter 250 microm) were removed distal to the site of occlusion and mounted in wire myographs. Endothelium-dependent relaxations to acetylcholine were determined in arteries pre-contracted by serotonin. Ischemia/reperfusion induced a marked decrease in the coronary responses to acetylcholine (maximal relaxations: sham 64+/-8%, n=8; ischemia/reperfusion: 41+/-9%, n=8 P<0.05). This impaired response was partially restored by MLA (55+/-4%, n=10 P<0.05 vs ischemia/reperfusion). The effect of MLA was not affected by aminoguanidine (57+/-5%, n=6). Thus, in addition to protecting myocytes, MLA induces a delayed protection against coronary endothelial dysfunction. However, in contrast to its effects on myocytes, the endothelial protective effects do not appear to involve iNOS.
Insights
Monophosphoryl lipid A (MLA) provides delayed protection against heart injury. This study shows MLA also protects coronary endothelium from reperfusion injury, independent of iNOS.
Area of Science:
- Cardiovascular Physiology
- Endothelial Biology
- Pharmacology
Background:
- Monophosphoryl lipid A (MLA) is known to induce delayed myocardial protection against ischemia/reperfusion injury.
- The potential of MLA to protect the endothelium, specifically coronary arteries, has not been previously investigated.
- Understanding MLA's endothelial effects is crucial as it mimics the second window of preconditioning.
Purpose of the Study:
- To evaluate the delayed protective effects of MLA against reperfusion-induced coronary endothelial dysfunction in rats.
- To investigate the role of inducible nitric oxide synthase (iNOS) in MLA-mediated endothelial protection.
Main Methods:
- Wistar rats received intravenous MLA or solvent, followed by a 20-minute ischemia and 60-minute reperfusion protocol 24 hours later.
- Coronary artery segments were isolated and mounted in wire myographs to assess endothelium-dependent relaxations to acetylcholine.
- The study included experiments with and without the iNOS inhibitor aminoguanidine.
Main Results:
- Ischemia/reperfusion significantly impaired endothelium-dependent coronary relaxations.
- MLA administration 24 hours prior to ischemia/reperfusion partially restored these impaired relaxations.
- The protective effect of MLA on coronary endothelium was not altered by the iNOS inhibitor aminoguanidine.
Conclusions:
- MLA confers delayed protection against coronary endothelial dysfunction induced by ischemia/reperfusion.
- Unlike its effects on myocytes, MLA's delayed endothelial protection does not appear to involve the iNOS pathway.
- MLA offers dual protection, safeguarding both cardiac myocytes and the coronary endothelium.
